Giuffre Randall Michael (CIK 1759822) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-06). Recent activity: Buy DMAC (6,175 shares), Buy DMAC (12,000 shares), Buy DMAC (5,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-06 | DiaMedica Therapeutics Inc. (DMAC) | Director | Buy | 6,175 | $51,994 |
| 2025-02-18 | DiaMedica Therapeutics Inc. (DMAC) | Director | Buy | 12,000 | $25,320 |
| 2025-02-18 | DiaMedica Therapeutics Inc. (DMAC) | Director | Buy | 5,000 | $18,250 |
Source: SEC Form 4 filings · as of 2026-01-06